Evaluation of Contextflow DETECT Lung CT Nodule Detection Software in Chest CT Scans
Evaluation of Computer-Aided Lung Nodule Detection Software in Chest CT Scans With an Assessment of Its Impact on Readers Decision-Making Process
1 other identifier
observational
337
1 country
1
Brief Summary
contextflow DETECT Lung CT is a Artificial Intelligence (AI)-based computed-aided detection (CADe) system, intended to support radiologists in the detection of lung nodules in chest computed tomography (CT) scans. System is intended to be used as a second-reader, therefore results provided by the software are meant to complement the radiologist's findings and decisions. Proposed study will be multi-reader, multi case (MRMC) retrospective reader study. The goal of the study is to evaluate the influence of CADe on the effectiveness of lung nodule detection. During the study, 10 radiologists will analyze 350 chest CT scans of adult patients, with and without the assistance of CADe. The study will be conducted remotely. CT scans will be uploaded to a web-based image submission and annotation platform, in which every participant of the study will be provided with individual account and assigned task list. The primary objective of the study determine if the diagnostic accuracy of radiologists with CADe assistance is superior to the diagnostic accuracy of radiologists without CADe assistance in localizing the pulmonary nodules with enhanced area under the free-response operating characteristic curve (AUC of FROC). The study will target approximately 350 asymptomatic adult patients, whose CT scans were acquired during routine CT examination. The patient population will include patients with and without lung nodules.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 28, 2022
CompletedFirst Posted
Study publicly available on registry
August 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedFebruary 8, 2023
February 1, 2023
7 months
July 28, 2022
February 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy
The primary objective of the reader study is to determine if the diagnostic accuracy of radiologists with CADe assistance is superior to the diagnostic accuracy of radiologists without CADe assistance in localizing the pulmonary nodules with enhanced area under the free-response operating characteristic curve (AUC of FROC). The true positive rate (or sensitivity) is calculated as the identified positive lesion among the true positive divided by the total number of true positive lesions among all images. The number of false positive findings is collected per image.
20 hours
Secondary Outcomes (2)
Disease diagnosis capabilities
20 hours
Disease identification capabilities
20 hours
Study Arms (1)
Asymptomatic adult patients
Interventions
Radiologists read chest CT scabs with and without the aid of contextflow DETECT Lung CT as a second reader
Eligibility Criteria
Asymptomatic adult patients (aged 22 or older), with or without pulmonary nodules detected during the routine chest CT scan. CT images taken with CT scanners provided by 3 different vendors, with 50% of images acquired from the US medical centers.
You may qualify if:
- adult asymptomatic patients, who undergo a routine chest CT scan.
You may not qualify if:
- symptomatic patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- contextflow GmbHlead
Study Sites (1)
contextflow GmbH
Vienna, 1050, Austria
Related Publications (3)
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008 Mar;246(3):697-722. doi: 10.1148/radiol.2462070712. Epub 2008 Jan 14.
PMID: 18195376BACKGROUNDSung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
PMID: 33538338BACKGROUNDQian F, Yang W, Chen Q, Zhang X, Han B. Screening for early stage lung cancer and its correlation with lung nodule detection. J Thorac Dis. 2018 Apr;10(Suppl 7):S846-S859. doi: 10.21037/jtd.2017.12.123.
PMID: 29780631BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2022
First Posted
August 1, 2022
Study Start
April 1, 2022
Primary Completion
October 30, 2022
Study Completion
October 30, 2022
Last Updated
February 8, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share
In this study, anonymized cases are used. There is no clear connection to patients or IPD included. The identification of cases selected for the study, as well as individual analyzes between readers will be blinded to readers.